3.97
price down icon6.15%   -0.26
pre-market  プレマーケット:  4.00   0.03   +0.76%
loading
前日終値:
$4.23
開ける:
$4.23
24時間の取引高:
1.05M
Relative Volume:
0.70
時価総額:
$394.33M
収益:
$58.36M
当期純損益:
$-25.72M
株価収益率:
-10.90
EPS:
-0.3641
ネットキャッシュフロー:
$-24.91M
1週間 パフォーマンス:
-1.24%
1か月 パフォーマンス:
+22.15%
6か月 パフォーマンス:
+26.43%
1年 パフォーマンス:
+31.02%
1日の値動き範囲:
Value
$3.955
$4.3199
1週間の範囲:
Value
$3.955
$4.50
52週間の値動き範囲:
Value
$2.12
$5.80

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
名前
Aquestive Therapeutics Inc
Name
セクター
Healthcare (1161)
Name
電話
908-941-1900
Name
住所
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
職員
142
Name
Twitter
Name
次回の収益日
2025-03-05
Name
最新のSEC提出書
Name
AQST's Discussions on Twitter

AQST を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
3.97 399.30M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.89 13.23B 2.99B 1.21B 1.13B 25.06

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-02 再開されました Oppenheimer Outperform
2024-12-17 開始されました Cantor Fitzgerald Overweight
2024-05-10 開始されました Leerink Partners Outperform
2024-04-11 開始されました Piper Sandler Overweight
2024-03-28 開始されました Raymond James Outperform
2021-04-07 再開されました RBC Capital Mkts Outperform
2019-04-22 開始されました H.C. Wainwright Buy
2019-01-03 開始されました Lake Street Buy
2018-08-20 開始されました JMP Securities Mkt Outperform
2018-08-20 開始されました RBC Capital Mkts Outperform
すべてを表示

Aquestive Therapeutics Inc (AQST) 最新ニュース

pulisher
03:00 AM

Is Aquestive Therapeutics Inc. a good long term investmentRobust financial gains - Autocar Professional

03:00 AM
pulisher
Jul 22, 2025

What drives Aquestive Therapeutics Inc. stock priceExceptional profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Aquestive Therapeutics Inc. Stock Analysis and ForecastSuperior profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

EpiPen Veteran to Lead Aquestive's Revolutionary Oral Epinephrine Launch as New Chief Commercial Officer - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

What analysts say about Aquestive Therapeutics Inc. stockExtraordinary profit generation - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

After Leaping 29% Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Are Not Flying Under The Radar - simplywall.st

Jul 21, 2025
pulisher
Jul 21, 2025

Aquestive's Anaphylm to be reviewed by Health Canada - MSN

Jul 21, 2025
pulisher
Jul 18, 2025

When is the best time to buy Aquestive Therapeutics Inc. stockAlpha Stock Ideas - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will Aquestive Therapeutics Inc. stock benefit from AI tech trendsFree Professional Portfolio Management - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionSteady Income Ideas - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Cantor Equity Partners I, Inc. shares rise 2.24% premarket after Aquestive Therapeutics' positive drug submission meeting with Health Canada. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

11,303 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Acquired by Cambridge Investment Research Advisors Inc. - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Aquestive Therapeutics Inc. stock price move sharplyFree High-Profit Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive's Anaphylm to be reviewed by Health Canada (AQST) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive schedules regulatory meetings for epinephrine film in Canada, EU - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

How Aquestive Therapeutics Inc. stock performs during market volatilityDaily Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive Therapeutics Says Canadian Regulator Has Granted Meeting to Discuss Anaphylm Approval - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive schedules regulatory meetings for epinephrine film in Canada, EU By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 14, 2025

Aquestive gains as allergy therapy undergoes FDA review - MSN

Jul 14, 2025
pulisher
Jul 11, 2025

Aquestive Therapeutics (AQST) Soars 3.97% on FDA NDA Acceptance - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Aquestive Therapeutics Inc. (AQST) Soars 8.97% on Positive EMA Opinion - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 09, 2025
pulisher
Jul 07, 2025

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism - The Manila Times

Jul 07, 2025
pulisher
Jul 07, 2025

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum on I&I and Metabolism - Nasdaq

Jul 07, 2025

Aquestive Therapeutics Inc (AQST) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$72.34
price up icon 1.09%
$14.93
price up icon 1.70%
$9.24
price up icon 3.82%
drug_manufacturers_specialty_generic RDY
$14.41
price down icon 0.96%
$132.75
price up icon 0.70%
$297.89
price up icon 1.63%
大文字化:     |  ボリューム (24 時間):